NCT05111678 is a clinical trial in Exposure to Polluted Air, sponsored by Turku University Hospital.

Who is sponsoring NCT05111678?

NCT05111678 is sponsored by Turku University Hospital.

What condition does NCT05111678 study?

NCT05111678 studies Exposure to Polluted Air.

Is NCT05111678 still recruiting?

NCT05111678 is currently completed. Last updated 10 April 2024.

Last reviewed 2024-04-10 · How we verify

NCT05111678

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Neurological Symptoms and Findings in Individuals Exposed to Indoor Air Pollutants

Completed Last updated 10 April 2024

What this trial tests

trial in Exposure to Polluted Air in 35 participants. Completed in 31 March 2024.

Timeline

1 April 2021

Primary endpoint
31 December 2023

31 March 2024

Quick facts

Lead sponsor	Turku University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	35
Start date	1 April 2021
Primary completion	31 December 2023
Estimated completion	31 March 2024
Sites	1 location across Finland

Conditions studied

Exposure to Polluted Air — all drugs for Exposure to Polluted Air →

Sponsor

Turku University Hospital

Who can join

18 and older, any sex, with Exposure to Polluted Air. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate neurological findings with TSPO-PET and MRI in patients who have been exposed to indoor air pollutants and have potentially neurological symptoms.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica.
van der Geest KSM, Sandovici M, Nienhuis PH, Slart RHJA, et al · · 2022 · cited 21× · PMID 35733858 · DOI 10.3389/fmed.2022.902155

Verify or expand the search:

Other Turku University Hospital trials

Trials by the same sponsor.

NCT07488494 — Effective Implementation of the Physical Activity and Motor Skills Intervention for 3-6-year-old Children With Cancer (E · NA · not yet recruiting
NCT07316868 — Neuroprotective Effect of Mild Hypothermia Versus Normothermia During Cardiopulmonary Bypass of Coronary Artery Surgery · NA · not yet recruiting
NCT07306000 — Pilot Study: Effects of CCP Intervention on NICU Environment and Preterm Infants Development · NA · recruiting
NCT07272824 — Usability Study of Gestational and Postpartum Weight Management Program · recruiting
NCT07310472 — Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05111678 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Turku University Hospital
Last refreshed: 10 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05111678.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing